Anti-calmodulins and Tricyclic Adjuvants in Pain Therapy Block the TRPV1 Channel
Zoltán Oláh, Katalin Jósvay, László Pecze et al. · 2007
Read Anti-calmodulins and Tricyclic Adjuvants in Pain Therapy Block the TRPV1 Channel by Zoltán Oláh, Katalin Jósvay, László Pecze et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0000545.txt.
Description
Zoltán Oláh and colleagues found that several pain drugs block a key pain channel, reporting in PLOS ONE in 2007. The channel is TRPV1, the heat and chili-pepper sensor on pain neurons, a prime target for new analgesics. Anti-calmodulins and tricyclic adjuvants used in pain therapy blocked the TRPV1 channel in their tests.
Tricyclic drugs are prescribed for chronic pain for reasons that were never fully clear. If part of their action is blocking TRPV1, an old drug gains a modern mechanism. Knowing the target also suggests designing cleaner blockers that keep the benefit without the tricyclics' broad side effects.
Catalog record
| CREATOR | Zoltán Oláh, Katalin Jósvay, László Pecze et al. |
|---|---|
| YEAR | 2007 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000545